SI-BONE, Inc. — Director's Dealing 2020

Feb 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2020-02-18

Reporting Person: FRANCIS LAURA (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-18	Common Stock	M	1194.00	$4.68	Acquired	141569.00	Direct
2020-02-18	Common Stock	S	1194.00	$20.4749	Disposed	140375.00	Direct
2020-02-18	Common Stock	M	7553.00	$4.32	Acquired	147928.00	Direct
2020-02-18	Common Stock	S	7553.00	$20.4749	Disposed	140375.00	Direct
2020-02-18	Common Stock	S	481.00	$20.37	Disposed	139894.00	Direct
2020-02-18	Common Stock	S	422.00	$20.37	Disposed	139472.00	Direct
2020-02-19	Common Stock	S	944.00	$21.2448	Disposed	138528.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-18	Stock Option (Right to Buy)	$4.68	M	1194.00	Disposed	2027-03-01	Common Stock (1194.00)	Direct
2020-02-18	Stock Option (Right to Buy)	$4.32	M	7553.00	Disposed	2025-05-25	Common Stock (7553.00)	Direct

Footnotes

F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.20 to $20.70, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $21.239 to $21.25, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: Includes 90,501 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

F6: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.